If you got the Johnson & Johnson vaccine, do you need another dose?

México Noticias Noticias

If you got the Johnson & Johnson vaccine, do you need another dose?
México Últimas Noticias,México Titulares
  • 📰 TODAYshow
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 55%

There's growing anxiety over the highly contagious delta variant in the U.S.

Since the beginning of the month, the U.S. has averaged 10,000 to 40,000 new cases a day, according to. At least 13 million people in the U.S. have received the single Johnson & Johnson dose — but experts say people shouldn't be rushing out to boost their Johnson & Johnson vaccinations with any other shots.

The study looked only at the antibody response in the blood samples, according to the researchers. Other crucial components of the immune response, such as T cells that can protect the body against the virus, weren't examined.Early this month, researchers from South Africa reported on their real world data about health care workers who had received the one-dose vaccine. The research, which has yet to be published, showed that, overall, over 90 percent of breakthrough infections were mild.

In a statement Tuesday, Johnson & Johnson responded that the new research doesn't show"the full nature of immune protection."

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

TODAYshow /  🏆 389. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

J&J Vaccine Less Effective Against Variants: StudyJ&J Vaccine Less Effective Against Variants: StudyA new study says the one-dose Johnson & Johnson vaccine provides less protection against the Delta and Lamba variants than against the original COVID-19 strain.
Leer más »

J&J forecasts $2.5B in revenue from Covid vaccine sales during 2021J&J forecasts $2.5B in revenue from Covid vaccine sales during 2021Although Johnson & Johnson raised its 2021 revenue estimates, its vaccine sales outlook pales in comparison with its peers, reflecting the widening gap in the global vaccine race.
Leer más »

Johnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says studyJohnson & Johnson COVID-19 vaccine may not perform as well against Delta variant, says studyThe study, which examined blood samples in a laboratory setting and has not yet been peer-reviewed, suggests that anyone who received the J&J vaccine may...
Leer más »

Johnson & Johnson expects $2.5 billion in global sales from Covid vaccine this yearJohnson & Johnson expects $2.5 billion in global sales from Covid vaccine this yearJ&J says it expects to sell $2.5 billion of its Covid-19 vaccine this year — CFO Joseph Wolk joined megtirrell to discuss Q2 results, the spread of the delta variant and more.
Leer más »

Eric Clapton Will Not Play Shows Where Proof of Vaccine Is RequiredEric Clapton Will Not Play Shows Where Proof of Vaccine Is RequiredMusician issued statement after U.K. Prime Minister Boris Johnson said vaccine passes would be required at clubs and venues
Leer más »

Drug distributors, Johnson & Johnson reach landmark $26 billion opioid settlementDrug distributors, Johnson & Johnson reach landmark $26 billion opioid settlementUnder the settlement, McKesson, Cardinal Health and AmerisourceBergen are expected to pay a combined $21 billion, while Johnson & Johnson would pay $5 billion.
Leer más »



Render Time: 2025-04-06 21:50:23